Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of RXI 109 for treatment of keloids

Trial Profile

Phase II trial of RXI 109 for treatment of keloids

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 19 Feb 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PH 109 (Primary)
  • Indications Keloids
  • Focus Therapeutic Use
  • Sponsors Phio Pharmaceuticals
  • Most Recent Events

    • 25 Mar 2015 New trial record
    • 23 Mar 2015 According to RXi Pharmaceuticals media release, this trial is expected to begin in near future.
    • 15 Feb 2015 Trial design presented at the 73rd Annual Meeting of the American Academy of Dermatology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top